Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib
既往存在的心血管疾病会增加接受伊布替尼治疗的癌症患者发生房性心律失常和死亡的风险。
期刊:Cardiooncology
影响因子:3.2
doi:10.1186/s40959-021-00125-8
Avalon, Juan Carlo; Fuqua, Jacob; Miller, Tyler; Deskins, Seth; Wakefield, Chelby; King, Austin; Inderbitzin-Brooks, Sonya; Bianco, Christopher; Veltri, Lauren; Fang, Wei; Craig, Michael; Kanate, Abraham; Ross, Kelly; Malla, Midhun; Patel, Brijesh
